InnoSkel Launches with €20 Million Series A Financing InnoSkel Launches with €20 Million Series A Financing Proceeds to support development and advancement of innovative gene therapies for patients with rare skeletal diseases Founded and led by...

Jeito Capital leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and leader in rare skeletal disorders Jeito Capital leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and leader in rare skeletal disorders Jeito’s third international investment in H2 2020, with deep and rapidly...

Jeito Capital co-leads $110 Million Series A Financing in Neogene Therapeutics Jeito Capital co-leads $110 Million Series A Financing in Neogene Therapeutics Neogene becomes Jeito Capital’s first investment following the fund I launch in January 2020Round co-led by Jeito...